Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

A live experimental vaccine against Burkholderia pseudomallei elicits CD4+ T cell-mediated immunity, priming T cells specific for 2 type III secretion system proteins.
Haque, A; Chu, K; Easton, A; Stevens, MP; Galyov, EE; Atkins, T; Titball, R; BANCROFT, GJ;
2006
The Journal of infectious diseases, (2006).194 9 10.1086/508217.
Differential evidence of natural selection on two leading sporozoite stage malaria vaccine candidate antigens.
Weedall, GD; Preston, BM; Thomas, AW; SUTHERLAND, CJ; CONWAY, DJ;
2006
The American journal of tropical medicine and hygiene, (2006).75 5
The effect of praziquantel treatment on immune responses against Schistosomiasis mansoni during pregnancy: Cytokine and antibody responses in pregnant women and their infants.
Tweyongyere, R; MAWA, PA; Namujju, PB; Jones, FM; Ndibazza, J; Omoding, N; Muhangi, L; Kabatereine, NB; Vennervald, BJ; Dunne, DW; Katunguka-Rwakishaya, E; ELLIOTT, AM;
2006
The American journal of tropical medicine and hygiene, (2006).75 5
Intermittent preventive malaria treatment delivered alongside routine vaccinations in Tanzanian infants: Coverage and impact on indicators of malaria and anaemia.
SCHELLENBERG, JA; Mayokola, W; Shirima, K; Yuna, H; Manzi, F; Mrisho, M; Alonso, P; Mshinda, H; Tanner, M; SCHELLENBERG, D;
2006
The American journal of tropical medicine and hygiene, (2006).75 5
Hookworm vaccines: past, present, and future.
Loukas, A; Bethony, J; BROOKER, S; Hotez, P;
2006
The Lancet infectious diseases, (2006).6 11 10.1016/S1473-3099(06)70630-2.
Safety and immunogenicity of the malaria candidate vaccines FP9 CS and MVA CS in adult Gambian men.
Imoukhuede, EB; Berthoud, T; MILLIGAN, P; BOJANG, K; Ismaili, J; Keating, S; NWAKANMA, D; Keita, S; NJIE, F; Sowe, M; Todryk, S; Laidlaw, SM; Skinner, MA; Lang, T; Gilbert, S; GREENWOOD, BM; Hill, AV S;
2006
Vaccine, (2006).24 42-43 10.1016/j.vaccine.2006.06.022.
A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya.
Bejon, P; Mwacharo, J; Kai, O; Mwangi, T; MILLIGAN, P; Todryk, S; Keating, S; Lang, T; Lowe, B; Gikonyo, C; Molyneux, C; Fegan, G; Gilbert, SC; Peshu, N; Marsh, K; Hill, AV S;
2006
PLoS clinical trials, (2006).1 6 10.1371/journal.pctr.0010029.
Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease.
Granger, R; Walters, J; Poole, PJ; Lasserson, TJ; MANGTANI, P; Cates, CJ; Wood-Baker, R;
2006
The Cochrane database of systematic reviews, (2006).4 4 10.1002/14651858.CD001390.pub2.
Cross-sectional survey of older peoples' views related to influenza vaccine uptake.
MANGTANI, P; Breeze, E; Stirling, S; Hanciles, S; KOVATS, S; FLETCHER, A;
2006
BMC public health, (2006).6 1 10.1186/1471-2458-6-249.
BCG vaccine effectiveness against Buruli ulcer: a case-control study in Benin.
Nackers, F; Dramaix, M; Johnson, RC; Zinsou, C; Robert, A; DE Biurrun Bakedano, E; GLYNN, JR; Portaels, F; Tonglet, R;
2006
The American journal of tropical medicine and hygiene, (2006).75 4 10.4269/ajtmh.2006.75.768.